Detection and surveillance of SARS-CoV-2 genomic variants in wastewater

Katharina Jahn, David Dreifuss, Ivan Topolsky, Anina Kull, Pravin Ganesanandamoorthy, Xavier Fernández-Cassi, Carola Bänziger, Alexander J. Devaux, Elyse Stachler, Lea Caduff, Federica Cariti, Álex Tuñas Corzón, Lara Fuhrmann, Chaoran Chen, Kim Philipp Jablonski, Sarah Nadeau, Mirjam Feldkamp, Christian Beisel, Catharine Aquino, Tanja Stadler, Christoph Ort, Tamar Kohn, Timothy R. Julian, Niko BeerenwinkelmedRxiv 2021 · DOI

Abstract

The emergence of SARS-CoV-2 mutants with altered transmissibility, virulence, or immunogenicity emphasizes the need for early detection and epidemiological surveillance of genomic variants. Wastewater samples provide an opportunity to assess circulating viral lineages in the community. We performed genomic sequencing of 122 wastewater samples from three locations in Switzerland to analyze the B.1.1.7, B.1.351, and P.1 variants of SARS-CoV-2 on a population level. We called variant-specific signature mutations and monitored variant prevalence in the local population over time. To enable early detection of emerging variants, we developed a bioinformatics tool that uses read pairs carrying multiple signature mutations as a robust indicator of low-frequency variants. We further devised a statistical approach to estimate the transmission fitness advantage, a key epidemiological parameter indicating the speed at which a variant spreads through the population, and compared the wastewater-based findings to those derived from clinical samples. We found that the local outbreak of the B.1.1.7 variant in two Swiss cities was observable in wastewater up to 8 days before its first detection in clinical samples. Our methodology provides a blueprint for rapid, unbiased, and cost-efficient genomic surveillance of SARS-CoV-2 variants.

Introduction

Throughout the COVID-19 pandemic, tracking the emergence of new variants of concern (VOCs) was a race against time. Traditional surveillance relies on sequencing individual clinical samples, which is often reactive, biased toward symptomatic individuals, and expensive to scale. Wastewater-based epidemiology (WBE) offers a non-invasive, unbiased alternative. Because infected individuals shed viral RNA in their stool—often before symptoms appear—sewage provides a community-wide snapshot of viral evolution. However, wastewater is a "noisy" mixture of fragmented RNA, making the detection of rare, emerging variants technically challenging. This paper presents a robust framework for using wastewater sequencing as a population-level early warning system.

Methods and Materials

The study analyzed 122 raw influent samples from Zurich, Lausanne, and a Swiss alpine resort between July 2020 and February 2021.

Sequencing and the Cojac Pipeline

Researchers utilized the ARTIC v3 protocol for amplicon-based next-generation sequencing (NGS). To address the noise inherent in wastewater samples, they developed a bioinformatics tool called Cojac (Co-occurrence adJusted Analysis and Calling). Instead of searching for single mutations—which could be sequencing errors—Cojac identifies multiple signature mutations occurring on the same 250bp read pair. Physical linkage on a single DNA fragment provides high statistical confidence that a specific variant is present, even at extremely low frequencies.

Wastewater surveillance workflow and data reproducibility. (A) Schematic of sample collection, processing, and variant calling. (B) High correlation (R=0.91) between sequencing replicates confirms the robustness of the variant detection pipeline.

Statistical Modeling

The team applied a logistic growth model to estimate the transmission fitness advantage ($f_d$), a metric indicating how much faster a new variant spreads compared to the resident strain. This allowed for the quantification of variant spread using significantly fewer samples than traditional clinical sequencing.

Key Results

Early Detection and Population Monitoring

The B.1.1.7 (Alpha) variant was detected in wastewater up to 13 days before the first clinical case in Lausanne, with a consistent lead time of approximately 8 days across the study. The method also identified a high prevalence of Alpha in an alpine resort popular with British tourists in December 2020, catching an importation event that clinical testing might have missed.

Fitness Advantage and Sensitivity

The transmission fitness advantage for B.1.1.7 was estimated at 46% in Zurich and 59% in Lausanne, aligning closely with estimates derived from much larger clinical datasets. Validation experiments using dilution series confirmed the method's high sensitivity, demonstrating the ability to detect variants even when they constituted a tiny fraction of the total viral load.

Sensitivity analysis showing the fraction of B.1.1.7 signature mutations detected across various dilution ratios (1:100, 1:50, 1:10).

Discussion and Limitations

While highly effective, the methodology faces challenges such as RNA degradation, which can break the physical linkage required for co-occurrence analysis. Additionally, mutations at primer binding sites can affect sequencing coverage. Despite these limitations, genomic sequencing of wastewater proves to be a powerful, cost-efficient "crystal ball" for public health. One wastewater sample can represent hundreds of thousands of people, providing a blueprint for the permanent surveillance of SARS-CoV-2 and other emerging pathogens.

Summary updated

Abstract

Abstract The emergence of SARS-CoV-2 mutants with altered transmissibility, virulence, or immunogenicity emphasizes the need for early detection and epidemiological surveillance of genomic variants. Wastewater samples provide an opportunity to assess circulating viral lineages in the community. We performed genomic sequencing of 122 wastewater samples from three locations in Switzerland to analyze the B.1.1.7, B.1.351, and P.1 variants of SARS-CoV-2 on a population level. We called variant-specific signature mutations and monitored variant prevalence in the local population over time. To enable early detection of emerging variants, we developed a bioinformatics tool that uses read pairs carrying multiple signature mutations as a robust indicator of low-frequency variants. We further devised a statistical approach to estimate the transmission fitness advantage, a key epidemiological parameter indicating the speed at which a variant spreads through the population, and compared the wastewater-based findings to those derived from clinical samples. We found that the local outbreak of the B.1.1.7 variant in two Swiss cities was observable in wastewater up to 8 days before its first detection in clinical samples. We detected a high prevalence of the B.1.1.7 variant in an alpine ski resort popular among British tourists in December 2020, a time when the variant was still very rare in Switzerland. We found no evidence of local spread of the B.1.351 and P.1 variants at the monitored locations until the end of the study (mid February) which is consistent with clinical samples. Estimation of local variant prevalence performs equally well or better for wastewater samples as for a much larger number of clinical samples. We found that the transmission fitness advantage of B.1.1.7, i.e. the relative change of its reproductive number, can be estimated earlier and based on substantially fewer wastewater samples as compared to using clinical samples. Our results show that genomic sequencing of wastewater samples can detect, monitor, and evaluate genetic variants of SARS-CoV-2 on a population level. Our methodology provides a blueprint for rapid, unbiased, and cost-efficient genomic surveillance of SARS-CoV-2 variants.
BibTeX
@misc{jahn2021detection,
  author = {Katharina Jahn and David Dreifuss and Ivan Topolsky and Anina Kull and Pravin Ganesanandamoorthy and Xavier Fernández-Cassi and Carola Bänziger and Alexander J. Devaux and Elyse Stachler and Lea Caduff and Federica Cariti and Álex Tuñas Corzón and Lara Fuhrmann and Chaoran Chen and Kim Philipp Jablonski and Sarah Nadeau and Mirjam Feldkamp and Christian Beisel and Catharine Aquino and Tanja Stadler and Christoph Ort and Tamar Kohn and Timothy R. Julian and Niko Beerenwinkel},
  title = {{Detection and surveillance of SARS-CoV-2 genomic variants in wastewater}},
  year = {2021},
  doi = {10.1101/2021.01.08.21249379},
  howpublished = {medRxiv},
}
Figure